Varaico: Literature-Extracted Genetic Variants

Gene:EGFR
Variant:p.R677C
Back to variants list

EGFR

NM_005228.5:p.R677C

Associated Papers

Epidermal Growth Factor Receptor Aberrations Identified by Next-Generation Sequencing in Patients with Metastatic Cancers.

Shin M et al.

Cancer Research and Treatment, 2025

Negative response to immunotherapy in dMMR or MSI-H gastric cancer with APC and PTEN mutations: a case report.

Liu J et al.

Frontiers in Oncology, 2024

Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8.

Toribio-Castelló S et al.

Cancers, 2023

37568638 (PubMed )
Supplement: cancers-15-03822-s001.zip › Supplementary_tables.xlsx › Table_S2

Clinicopathologic and molecular characteristics of EGFR-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapy.

Yu L et al.

Translational Lung Cancer Research, 2022

The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification.

Yang Y et al.

Bmc Cancer, 2022

35180847 (PubMed )
Supplement: 12885_2022_9279_MOESM3_ESM.xlsx › sheet1

Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients.

He C et al.

Journal of Cancer Research and Clinical Oncology, 2022

Single nucleotide polymorphisms of HER2 related to osteosarcoma susceptibility.

Xin DJ et al.

International Journal of Clinical and Experimental Pathology, 2015

Discrepancies in cancer genomic sequencing highlight opportunities for driver mutation discovery.

Hudson AM et al.

Cancer Research, 2014

The mutational burdens and evolutionary ages of early gastric cancers are comparable to those of advanced gastric cancers.

Kim TM et al.

The Journal of Pathology, 2014

Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung.

Marchetti A et al.

Human Mutation, 2008

Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomas.

van de Geer WS et al.

Neuro-oncology Advances, 0

35047820 (PubMed )
Supplement: vdab177_suppl_supplementary_data.xlsx › Figure5
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."